Literature DB >> 10078553

Molecular cloning of a pancreatic islet-specific glucose-6-phosphatase catalytic subunit-related protein.

S D Arden1, T Zahn, S Steegers, S Webb, B Bergman, R M O'Brien, J C Hutton.   

Abstract

A pancreatic islet-specific glucose-6-phosphatase-related protein (IGRP) was cloned using a subtractive cDNA expression cloning procedure from mouse insulinoma tissue. Two alternatively spliced variants that differed by the presence or absence of a 118-bp exon (exon IV) were detected in normal balb/c mice, diabetic ob/ob mice, and insulinoma tissue. The longer, 1901-bp full-length cDNA encoded a 355-amino acid protein (molecular weight 40,684) structurally related (50% overall identity) to the liver glucose-6-phosphatase and exhibited similar predicted transmembrane topology, conservation of catalytically important residues, and the presence of an endoplasmic reticulum retention signal. The shorter transcript encoded two possible open reading frames (ORFs), neither of which possessed His174, a residue thought to be the phosphoryl acceptor (Pan CJ, Lei KJ, Annabi B, Hemrika W, Chou JY: Transmembrane topology of glucose-6-phosphatase. J Biol Chem 273:6144-6148, 1998). Northern blot and reverse transcription-polymerase chain reaction analysis showed that the mRNA was highly expressed in pancreatic islets and expressed more in beta-cell lines than in an alpha-cell line. It was notably absent in tissues and cell lines of non-islet neuroendocrine origin, and no other major tissue source of the mRNA was found. During development, it was expressed in parallel with insulin mRNA. The mRNA was efficiently translated and glycosylated in an in vitro translation/membrane translocation system and readily transcribed into COS 1, HIT, and CHO cells using cytomegalovirus or Rous sarcoma virus promoters. Whereas the liver glucose-6-phosphatase showed activity in these transfection systems, the IGRP failed to show glucose phosphotransferase or phosphatase activity with p-nitrophenol phosphate, inorganic pyrophosphate, or a range of sugar phosphates hydrolyzed by the liver enzyme. While the metabolic function of the enzyme is not resolved, its remarkable tissue-specific expression warrants further investigation, as does its transcriptional regulation in conditions where glucose responsiveness of the pancreatic islet is altered.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10078553     DOI: 10.2337/diabetes.48.3.531

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  40 in total

1.  A pancreatic beta-cell-specific homolog of glucose-6-phosphatase emerges as a major target of cell-mediated autoimmunity in diabetes.

Authors:  John C Hutton; George S Eisenbarth
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-14       Impact factor: 11.205

2.  Human lysophosphatidylcholine acyltransferases 1 and 2 are located in lipid droplets where they catalyze the formation of phosphatidylcholine.

Authors:  Christine Moessinger; Lars Kuerschner; Johanna Spandl; Andrej Shevchenko; Christoph Thiele
Journal:  J Biol Chem       Date:  2011-04-15       Impact factor: 5.157

3.  A genetic variant of G6PC2 is associated with type 2 diabetes and fasting plasma glucose level in the Chinese population.

Authors:  C Hu; R Zhang; C Wang; X Ma; C Wang; Q Fang; Y Bao; K Xiang; W Jia
Journal:  Diabetologia       Date:  2008-12-13       Impact factor: 10.122

4.  Characterization of the mouse pancreatic islet proteome and comparative analysis with other mouse tissues.

Authors:  Vladislav A Petyuk; Wei-Jun Qian; Charlotte Hinault; Marina A Gritsenko; Mudita Singhal; Matthew E Monroe; David G Camp; Rohit N Kulkarni; Richard D Smith
Journal:  J Proteome Res       Date:  2008-06-21       Impact factor: 4.466

5.  Candidate genes for plasma triglyceride, FFA, and glucose revealed from an intercross between inbred mouse strains NZB/B1NJ and NZW/LacJ.

Authors:  Zhiguang Su; Shirng-wern Tsaih; Jin Szatkiewicz; Yuan Shen; Beverly Paigen
Journal:  J Lipid Res       Date:  2008-03-24       Impact factor: 5.922

6.  In islet-specific glucose-6-phosphatase-related protein, the beta cell antigenic sequence that is targeted in diabetes is not responsible for the loss of phosphohydrolase activity.

Authors:  J-J Shieh; C-J Pan; B C Mansfield; J Y Chou
Journal:  Diabetologia       Date:  2005-07-13       Impact factor: 10.122

7.  Kinetics of the post-onset decline in zinc transporter 8 autoantibodies in type 1 diabetic human subjects.

Authors:  J M Wenzlau; M Walter; T J Gardner; L M Frisch; L Yu; G S Eisenbarth; A-G Ziegler; H W Davidson; J C Hutton
Journal:  J Clin Endocrinol Metab       Date:  2010-07-07       Impact factor: 5.958

Review 8.  Islet autoantigens: structure, function, localization, and regulation.

Authors:  Peter Arvan; Massimo Pietropaolo; David Ostrov; Christopher J Rhodes
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

Review 9.  Glucose-6-phosphatase catalytic subunit gene family.

Authors:  John C Hutton; Richard M O'Brien
Journal:  J Biol Chem       Date:  2009-08-20       Impact factor: 5.157

10.  Cytokine-induced dicing and splicing in the beta-cell and the immune response in type 1 diabetes.

Authors:  John C Hutton; Howard W Davidson
Journal:  Diabetes       Date:  2010-02       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.